Outcomes after intestinal transplantation: A single-center experience over a decade

Transplantation Proceedings

Volumn 34, Issue 3, 2002, Pages 896-897

  Farmer, D G ^a,b   McDiarmid, S V ^a   Yersiz, H ^a   Cortina, G ^a   Vargas, J ^a   Maxfield, A J ^a   Vandenbogaart, B ^a   Correa, M ^a   Kroeber, A ^a   Geevarghese, S ^a   Busuttil, R W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; HUMAN; IMMUNOTHERAPY; INTESTINE TRANSPLANTATION; PARENTERAL NUTRITION; PATIENT CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GANCICLOVIR; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINAL DISEASES; INTESTINES; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036258925     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)02657-X     Document Type: Conference Paper

References (6)